A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization
Alexandra R. Brown(University of Kansas Medical Center), Richard J. Barohn(University of Missouri), Dinesh Pal Mudaranthakam(University of Kansas Medical Center), Mazen M. Dimachkie(University of Kansas Medical Center), Mamatha Pasnoor, Omar Jawdat, Suzanne Hunt(University of Kansas Medical Center), Melanie Quintana(Berry & Associates (United States)), Laura Herbelin, Byron J. Gajewski(University of Kansas Medical Center), Lauren S. Aaronson(University of Kansas Medical Center), Scott Berry(Queen's University)
Cited by 26
Related Papers
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818